Apokyn Bertek Pharmaceuticals - Treatment for Parkinson’s Disease

Apokyn (apomorphine hydrochloride injection) is the first and only therapy in the United States for the acute, intermittent treatment of hypomobility, “off” episodes (“end-of-dose wearing off” and unpredictable “on/off” episodes) associated with advanced Parkinson’s disease.

Posted: April 2004

Apokyn (apomorphine) FDA Approval History

View comments

Hide
(web3)